Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IKZF1
|
ENSG00000185811.12 | IKAROS family zinc finger 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IKZF1 | hg19_v2_chr7_+_50348268_50348366 | -0.36 | 4.4e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_150038704 | 6.97 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
chr16_-_31147020 | 4.18 |
ENST00000568261.1
ENST00000567797.1 ENST00000317508.6 |
PRSS8
|
protease, serine, 8 |
chr11_+_114166536 | 3.83 |
ENST00000299964.3
|
NNMT
|
nicotinamide N-methyltransferase |
chr19_+_45418067 | 3.69 |
ENST00000589078.1
ENST00000586638.1 |
APOC1
|
apolipoprotein C-I |
chr12_+_7167980 | 3.65 |
ENST00000360817.5
ENST00000402681.3 |
C1S
|
complement component 1, s subcomponent |
chr12_-_57630873 | 3.61 |
ENST00000556732.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr7_+_142829162 | 3.52 |
ENST00000291009.3
|
PIP
|
prolactin-induced protein |
chr16_-_28550320 | 3.49 |
ENST00000395641.2
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr16_-_31146961 | 3.46 |
ENST00000567531.1
|
PRSS8
|
protease, serine, 8 |
chr9_-_33402506 | 3.46 |
ENST00000377425.4
ENST00000537089.1 ENST00000297988.1 ENST00000539936.1 ENST00000541274.1 |
AQP7
|
aquaporin 7 |
chr12_-_7245018 | 3.42 |
ENST00000543835.1
ENST00000535233.2 |
C1R
|
complement component 1, r subcomponent |
chr16_-_28550348 | 3.40 |
ENST00000324873.6
|
NUPR1
|
nuclear protein, transcriptional regulator, 1 |
chr2_+_120187465 | 3.34 |
ENST00000409826.1
ENST00000417645.1 |
TMEM37
|
transmembrane protein 37 |
chr16_+_4845379 | 3.29 |
ENST00000588606.1
ENST00000586005.1 |
SMIM22
|
small integral membrane protein 22 |
chr12_-_7245125 | 3.28 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
chr11_+_114168085 | 3.27 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr5_+_78407602 | 3.25 |
ENST00000274353.5
ENST00000524080.1 |
BHMT
|
betaine--homocysteine S-methyltransferase |
chr3_-_149095652 | 3.20 |
ENST00000305366.3
|
TM4SF1
|
transmembrane 4 L six family member 1 |
chr19_+_45417921 | 3.17 |
ENST00000252491.4
ENST00000592885.1 ENST00000589781.1 |
APOC1
|
apolipoprotein C-I |
chr19_+_45409011 | 3.13 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
chr17_-_34313685 | 3.13 |
ENST00000435911.2
ENST00000586216.1 ENST00000394509.4 |
CCL14
|
chemokine (C-C motif) ligand 14 |
chr1_-_27701307 | 3.12 |
ENST00000270879.4
ENST00000354982.2 |
FCN3
|
ficolin (collagen/fibrinogen domain containing) 3 |
chr2_-_56150184 | 3.10 |
ENST00000394554.1
|
EFEMP1
|
EGF containing fibulin-like extracellular matrix protein 1 |
chr1_-_17307173 | 3.10 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr1_-_1293904 | 3.09 |
ENST00000309212.6
ENST00000342753.4 ENST00000445648.2 |
MXRA8
|
matrix-remodelling associated 8 |
chr12_-_15374343 | 3.08 |
ENST00000256953.2
ENST00000546331.1 |
RERG
|
RAS-like, estrogen-regulated, growth inhibitor |
chr20_+_44098346 | 3.03 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr17_+_1666108 | 3.02 |
ENST00000570731.1
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr6_+_32006042 | 2.93 |
ENST00000418967.2
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr10_-_45474237 | 2.90 |
ENST00000448778.1
ENST00000298295.3 |
C10orf10
|
chromosome 10 open reading frame 10 |
chr12_+_53491220 | 2.89 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr4_+_106816592 | 2.88 |
ENST00000379987.2
ENST00000453617.2 ENST00000427316.2 ENST00000514622.1 ENST00000305572.8 |
NPNT
|
nephronectin |
chr5_-_38595498 | 2.84 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr19_+_45312310 | 2.84 |
ENST00000589651.1
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group) |
chr17_-_53800217 | 2.82 |
ENST00000424486.2
|
TMEM100
|
transmembrane protein 100 |
chr11_-_119293872 | 2.81 |
ENST00000524970.1
|
THY1
|
Thy-1 cell surface antigen |
chr12_+_52306113 | 2.79 |
ENST00000547400.1
ENST00000550683.1 ENST00000419526.2 |
ACVRL1
|
activin A receptor type II-like 1 |
chr1_-_153599732 | 2.75 |
ENST00000392623.1
|
S100A13
|
S100 calcium binding protein A13 |
chr11_+_114168773 | 2.74 |
ENST00000542647.1
ENST00000545255.1 |
NNMT
|
nicotinamide N-methyltransferase |
chr13_+_110958124 | 2.74 |
ENST00000400163.2
|
COL4A2
|
collagen, type IV, alpha 2 |
chr1_+_22963158 | 2.73 |
ENST00000438241.1
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr12_-_7281469 | 2.73 |
ENST00000542370.1
ENST00000266560.3 |
RBP5
|
retinol binding protein 5, cellular |
chr12_-_7245080 | 2.72 |
ENST00000541042.1
ENST00000540242.1 |
C1R
|
complement component 1, r subcomponent |
chr19_+_7828035 | 2.70 |
ENST00000327325.5
ENST00000394122.2 ENST00000248228.4 ENST00000334806.5 ENST00000359059.5 ENST00000357361.2 ENST00000596363.1 ENST00000595751.1 ENST00000596707.1 ENST00000597522.1 ENST00000595496.1 |
CLEC4M
|
C-type lectin domain family 4, member M |
chr11_-_10590238 | 2.69 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr2_-_217560248 | 2.69 |
ENST00000233813.4
|
IGFBP5
|
insulin-like growth factor binding protein 5 |
chr20_+_30598231 | 2.65 |
ENST00000300415.8
ENST00000262659.8 |
CCM2L
|
cerebral cavernous malformation 2-like |
chr12_-_56101647 | 2.62 |
ENST00000347027.6
ENST00000257879.6 ENST00000257880.7 ENST00000394230.2 ENST00000394229.2 |
ITGA7
|
integrin, alpha 7 |
chr5_-_138842286 | 2.61 |
ENST00000515823.1
|
ECSCR
|
endothelial cell surface expressed chemotaxis and apoptosis regulator |
chr11_-_119211525 | 2.59 |
ENST00000528368.1
|
C1QTNF5
|
C1q and tumor necrosis factor related protein 5 |
chr7_-_120498357 | 2.59 |
ENST00000415871.1
ENST00000222747.3 ENST00000430985.1 |
TSPAN12
|
tetraspanin 12 |
chr8_+_121137333 | 2.58 |
ENST00000309791.4
ENST00000297848.3 ENST00000247781.3 |
COL14A1
|
collagen, type XIV, alpha 1 |
chr4_-_55991752 | 2.55 |
ENST00000263923.4
|
KDR
|
kinase insert domain receptor (a type III receptor tyrosine kinase) |
chr11_-_61687739 | 2.55 |
ENST00000531922.1
ENST00000301773.5 |
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr1_-_151345159 | 2.55 |
ENST00000458566.1
ENST00000447402.3 ENST00000426705.2 ENST00000435071.1 ENST00000368868.5 |
SELENBP1
|
selenium binding protein 1 |
chr19_+_45417504 | 2.52 |
ENST00000588750.1
ENST00000588802.1 |
APOC1
|
apolipoprotein C-I |
chr12_-_7245152 | 2.49 |
ENST00000542220.2
|
C1R
|
complement component 1, r subcomponent |
chr1_-_79472365 | 2.49 |
ENST00000370742.3
|
ELTD1
|
EGF, latrophilin and seven transmembrane domain containing 1 |
chr20_+_36974759 | 2.48 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
chr14_-_92414294 | 2.48 |
ENST00000554468.1
|
FBLN5
|
fibulin 5 |
chr11_-_10590118 | 2.48 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr16_+_20420849 | 2.48 |
ENST00000575584.1
ENST00000331849.4 |
ACSM5
|
acyl-CoA synthetase medium-chain family member 5 |
chr1_-_153600656 | 2.47 |
ENST00000339556.4
ENST00000440685.2 |
S100A13
|
S100 calcium binding protein A13 |
chr20_+_44098385 | 2.45 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr19_+_48216600 | 2.45 |
ENST00000263277.3
ENST00000538399.1 |
EHD2
|
EH-domain containing 2 |
chr1_+_22138758 | 2.43 |
ENST00000344642.2
ENST00000543870.1 |
LDLRAD2
|
low density lipoprotein receptor class A domain containing 2 |
chr10_-_7661623 | 2.40 |
ENST00000298441.6
|
ITIH5
|
inter-alpha-trypsin inhibitor heavy chain family, member 5 |
chr11_-_14993819 | 2.39 |
ENST00000396372.2
ENST00000361010.3 ENST00000359642.3 ENST00000331587.4 |
CALCA
|
calcitonin-related polypeptide alpha |
chr11_-_119293903 | 2.38 |
ENST00000580275.1
|
THY1
|
Thy-1 cell surface antigen |
chr11_-_119187826 | 2.36 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
chr7_+_30960915 | 2.35 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr8_-_119964434 | 2.35 |
ENST00000297350.4
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b |
chr11_+_111789580 | 2.33 |
ENST00000278601.5
|
C11orf52
|
chromosome 11 open reading frame 52 |
chr6_-_112575687 | 2.33 |
ENST00000521398.1
ENST00000424408.2 ENST00000243219.3 |
LAMA4
|
laminin, alpha 4 |
chr17_+_39975455 | 2.32 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr8_+_17434689 | 2.31 |
ENST00000398074.3
|
PDGFRL
|
platelet-derived growth factor receptor-like |
chr6_-_32077100 | 2.30 |
ENST00000375244.3
ENST00000375247.2 |
TNXB
|
tenascin XB |
chr17_-_34329084 | 2.27 |
ENST00000354059.4
ENST00000536149.1 |
CCL15
CCL14
|
chemokine (C-C motif) ligand 15 chemokine (C-C motif) ligand 14 |
chr7_-_73184588 | 2.27 |
ENST00000395145.2
|
CLDN3
|
claudin 3 |
chr7_+_100199800 | 2.26 |
ENST00000223061.5
|
PCOLCE
|
procollagen C-endopeptidase enhancer |
chr19_-_14168391 | 2.26 |
ENST00000589048.1
|
PALM3
|
paralemmin 3 |
chr17_+_41005283 | 2.24 |
ENST00000592999.1
|
AOC3
|
amine oxidase, copper containing 3 |
chr5_-_115152651 | 2.22 |
ENST00000250535.4
|
CDO1
|
cysteine dioxygenase type 1 |
chr11_+_114128522 | 2.20 |
ENST00000535401.1
|
NNMT
|
nicotinamide N-methyltransferase |
chr17_+_77019030 | 2.19 |
ENST00000580454.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr18_-_47376197 | 2.19 |
ENST00000592688.1
|
MYO5B
|
myosin VB |
chr7_+_45197383 | 2.19 |
ENST00000242249.4
ENST00000496212.1 ENST00000481345.1 |
RAMP3
|
receptor (G protein-coupled) activity modifying protein 3 |
chr12_+_53443963 | 2.18 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr2_-_211090162 | 2.16 |
ENST00000233710.3
|
ACADL
|
acyl-CoA dehydrogenase, long chain |
chr12_+_53342625 | 2.15 |
ENST00000388837.2
ENST00000550600.1 ENST00000388835.3 |
KRT18
|
keratin 18 |
chr12_-_77272765 | 2.14 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chr7_+_94023873 | 2.13 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
chr1_+_22962948 | 2.13 |
ENST00000374642.3
|
C1QA
|
complement component 1, q subcomponent, A chain |
chr17_+_39975544 | 2.12 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr1_-_153599426 | 2.12 |
ENST00000392622.1
|
S100A13
|
S100 calcium binding protein A13 |
chr18_+_47088401 | 2.12 |
ENST00000261292.4
ENST00000427224.2 ENST00000580036.1 |
LIPG
|
lipase, endothelial |
chr11_+_27062272 | 2.12 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr21_-_43735628 | 2.11 |
ENST00000291525.10
ENST00000518498.1 |
TFF3
|
trefoil factor 3 (intestinal) |
chr22_+_31488433 | 2.11 |
ENST00000455608.1
|
SMTN
|
smoothelin |
chr11_+_76493294 | 2.10 |
ENST00000533752.1
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr1_-_153581798 | 2.09 |
ENST00000368704.1
ENST00000368705.2 |
S100A16
|
S100 calcium binding protein A16 |
chr7_+_33945106 | 2.08 |
ENST00000426693.1
|
BMPER
|
BMP binding endothelial regulator |
chr3_+_46921732 | 2.08 |
ENST00000418619.1
|
PTH1R
|
parathyroid hormone 1 receptor |
chr6_-_112575758 | 2.07 |
ENST00000431543.2
ENST00000453937.2 ENST00000368638.4 ENST00000389463.4 |
LAMA4
|
laminin, alpha 4 |
chr11_-_77734260 | 2.06 |
ENST00000353172.5
|
KCTD14
|
potassium channel tetramerization domain containing 14 |
chr16_-_75299884 | 2.04 |
ENST00000538440.2
ENST00000418647.3 |
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr6_+_32006159 | 2.03 |
ENST00000478281.1
ENST00000471671.1 ENST00000435122.2 |
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2 |
chr9_+_13446472 | 2.02 |
ENST00000428006.2
|
RP11-536O18.1
|
RP11-536O18.1 |
chr17_+_77018896 | 2.01 |
ENST00000578229.1
|
C1QTNF1
|
C1q and tumor necrosis factor related protein 1 |
chr11_+_69931519 | 2.00 |
ENST00000316296.5
ENST00000530676.1 |
ANO1
|
anoctamin 1, calcium activated chloride channel |
chr7_-_99573677 | 2.00 |
ENST00000292401.4
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
chr19_+_45312347 | 2.00 |
ENST00000270233.6
ENST00000591520.1 |
BCAM
|
basal cell adhesion molecule (Lutheran blood group) |
chr13_-_110959478 | 1.99 |
ENST00000543140.1
ENST00000375820.4 |
COL4A1
|
collagen, type IV, alpha 1 |
chr9_+_139553306 | 1.99 |
ENST00000371699.1
|
EGFL7
|
EGF-like-domain, multiple 7 |
chr1_-_153585539 | 1.98 |
ENST00000368706.4
|
S100A16
|
S100 calcium binding protein A16 |
chr19_+_15218180 | 1.98 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chr3_-_50360192 | 1.97 |
ENST00000442581.1
ENST00000447092.1 ENST00000357750.4 |
HYAL2
|
hyaluronoglucosaminidase 2 |
chr19_+_45417812 | 1.97 |
ENST00000592535.1
|
APOC1
|
apolipoprotein C-I |
chr7_+_89783689 | 1.95 |
ENST00000297205.2
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1 |
chr6_-_112575912 | 1.95 |
ENST00000522006.1
ENST00000230538.7 ENST00000519932.1 |
LAMA4
|
laminin, alpha 4 |
chr6_-_75828774 | 1.95 |
ENST00000493109.2
|
COL12A1
|
collagen, type XII, alpha 1 |
chr9_+_133320339 | 1.94 |
ENST00000372394.1
ENST00000372393.3 ENST00000422569.1 |
ASS1
|
argininosuccinate synthase 1 |
chr2_+_120189422 | 1.93 |
ENST00000306406.4
|
TMEM37
|
transmembrane protein 37 |
chr4_+_111397216 | 1.93 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr19_+_45445491 | 1.93 |
ENST00000592954.1
ENST00000419266.2 ENST00000589057.1 |
APOC4
APOC4-APOC2
|
apolipoprotein C-IV APOC4-APOC2 readthrough (NMD candidate) |
chr1_+_47264711 | 1.92 |
ENST00000371923.4
ENST00000271153.4 ENST00000371919.4 |
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1 |
chr19_-_54984354 | 1.92 |
ENST00000301200.2
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5 |
chr22_-_43090992 | 1.92 |
ENST00000401850.1
|
A4GALT
|
alpha 1,4-galactosyltransferase |
chr11_-_124767693 | 1.91 |
ENST00000533054.1
|
ROBO4
|
roundabout, axon guidance receptor, homolog 4 (Drosophila) |
chr3_-_195310802 | 1.90 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr12_+_13044787 | 1.90 |
ENST00000534831.1
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A |
chr2_-_89278535 | 1.89 |
ENST00000390247.2
|
IGKV3-7
|
immunoglobulin kappa variable 3-7 (non-functional) |
chr20_+_30063067 | 1.88 |
ENST00000201979.2
|
REM1
|
RAS (RAD and GEM)-like GTP-binding 1 |
chr6_+_31916733 | 1.88 |
ENST00000483004.1
|
CFB
|
complement factor B |
chrX_-_15511438 | 1.88 |
ENST00000380420.5
|
PIR
|
pirin (iron-binding nuclear protein) |
chr19_-_46272462 | 1.88 |
ENST00000317578.6
|
SIX5
|
SIX homeobox 5 |
chr22_+_23241661 | 1.88 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr14_-_24804269 | 1.85 |
ENST00000310677.4
ENST00000554068.2 ENST00000559167.1 ENST00000561138.1 |
ADCY4
|
adenylate cyclase 4 |
chr1_+_43766668 | 1.85 |
ENST00000441333.2
ENST00000538015.1 |
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chrX_+_128872918 | 1.85 |
ENST00000371105.3
|
XPNPEP2
|
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound |
chr11_-_18258342 | 1.84 |
ENST00000278222.4
|
SAA4
|
serum amyloid A4, constitutive |
chr17_+_40913264 | 1.84 |
ENST00000587142.1
ENST00000588576.1 |
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr12_-_88974236 | 1.84 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
chr12_+_3069037 | 1.84 |
ENST00000397122.2
|
TEAD4
|
TEA domain family member 4 |
chr12_-_53343560 | 1.83 |
ENST00000548998.1
|
KRT8
|
keratin 8 |
chr3_+_153839149 | 1.83 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr11_-_9482010 | 1.82 |
ENST00000596206.1
|
AC132192.1
|
LOC644656 protein; Uncharacterized protein |
chr10_-_5046042 | 1.82 |
ENST00000421196.3
ENST00000455190.1 |
AKR1C2
|
aldo-keto reductase family 1, member C2 |
chr1_+_43766642 | 1.82 |
ENST00000372476.3
|
TIE1
|
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
chr15_-_54051831 | 1.81 |
ENST00000557913.1
ENST00000360509.5 |
WDR72
|
WD repeat domain 72 |
chr2_-_20424844 | 1.80 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr3_-_87040233 | 1.80 |
ENST00000398399.2
|
VGLL3
|
vestigial like 3 (Drosophila) |
chr5_+_38258511 | 1.80 |
ENST00000354891.3
ENST00000322350.5 |
EGFLAM
|
EGF-like, fibronectin type III and laminin G domains |
chr19_+_17905919 | 1.80 |
ENST00000318683.6
ENST00000600777.1 ENST00000595387.1 |
B3GNT3
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 |
chr9_+_133320301 | 1.80 |
ENST00000352480.5
|
ASS1
|
argininosuccinate synthase 1 |
chr1_-_151342180 | 1.79 |
ENST00000424475.1
|
SELENBP1
|
selenium binding protein 1 |
chr3_+_100211412 | 1.79 |
ENST00000323523.4
ENST00000403410.1 ENST00000449609.1 |
TMEM45A
|
transmembrane protein 45A |
chr8_+_136469684 | 1.79 |
ENST00000355849.5
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3 |
chr5_+_52776449 | 1.78 |
ENST00000396947.3
|
FST
|
follistatin |
chr12_-_6484376 | 1.78 |
ENST00000360168.3
ENST00000358945.3 |
SCNN1A
|
sodium channel, non-voltage-gated 1 alpha subunit |
chr10_-_131640435 | 1.78 |
ENST00000440978.1
|
EBF3
|
early B-cell factor 3 |
chr19_-_36499521 | 1.77 |
ENST00000397428.3
ENST00000503121.1 ENST00000340477.5 ENST00000324444.3 ENST00000490730.1 |
SYNE4
|
spectrin repeat containing, nuclear envelope family member 4 |
chr3_-_49722523 | 1.77 |
ENST00000448220.1
|
MST1
|
macrophage stimulating 1 (hepatocyte growth factor-like) |
chr14_+_24867992 | 1.77 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr7_+_44143925 | 1.77 |
ENST00000223357.3
|
AEBP1
|
AE binding protein 1 |
chr1_-_59043166 | 1.77 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr12_+_49961990 | 1.77 |
ENST00000551063.1
|
PRPF40B
|
PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae) |
chr19_-_16045619 | 1.76 |
ENST00000402119.4
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11 |
chr17_-_19290483 | 1.76 |
ENST00000395592.2
ENST00000299610.4 |
MFAP4
|
microfibrillar-associated protein 4 |
chr17_-_39681578 | 1.76 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr17_+_8213590 | 1.76 |
ENST00000361926.3
|
ARHGEF15
|
Rho guanine nucleotide exchange factor (GEF) 15 |
chr17_-_77925806 | 1.76 |
ENST00000574241.2
|
TBC1D16
|
TBC1 domain family, member 16 |
chr20_-_6034672 | 1.75 |
ENST00000378858.4
|
LRRN4
|
leucine rich repeat neuronal 4 |
chr1_+_203444887 | 1.75 |
ENST00000343110.2
|
PRELP
|
proline/arginine-rich end leucine-rich repeat protein |
chr12_-_8814669 | 1.74 |
ENST00000535411.1
ENST00000540087.1 |
MFAP5
|
microfibrillar associated protein 5 |
chr22_-_24303340 | 1.73 |
ENST00000404172.3
ENST00000290765.4 |
GSTT2B
|
glutathione S-transferase theta 2B (gene/pseudogene) |
chr1_-_53387386 | 1.73 |
ENST00000467988.1
ENST00000358358.5 ENST00000371522.4 |
ECHDC2
|
enoyl CoA hydratase domain containing 2 |
chr4_-_187644930 | 1.73 |
ENST00000441802.2
|
FAT1
|
FAT atypical cadherin 1 |
chr5_+_131593364 | 1.73 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr17_-_19648916 | 1.72 |
ENST00000444455.1
ENST00000439102.2 |
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1 |
chr22_-_37915247 | 1.72 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr13_+_110959598 | 1.72 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr12_+_54519842 | 1.72 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
chr15_+_96875657 | 1.71 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr2_-_238499725 | 1.71 |
ENST00000264601.3
|
RAB17
|
RAB17, member RAS oncogene family |
chr6_+_32132360 | 1.71 |
ENST00000333845.6
ENST00000395512.1 ENST00000432129.1 |
EGFL8
|
EGF-like-domain, multiple 8 |
chr19_-_17375527 | 1.70 |
ENST00000431146.2
ENST00000594190.1 |
USHBP1
|
Usher syndrome 1C binding protein 1 |
chr17_-_7166500 | 1.70 |
ENST00000575313.1
ENST00000397317.4 |
CLDN7
|
claudin 7 |
chr11_-_49230184 | 1.69 |
ENST00000340334.7
ENST00000256999.2 |
FOLH1
|
folate hydrolase (prostate-specific membrane antigen) 1 |
chr1_-_95391315 | 1.68 |
ENST00000545882.1
ENST00000415017.1 |
CNN3
|
calponin 3, acidic |
chr19_-_36247910 | 1.67 |
ENST00000587965.1
ENST00000004982.3 |
HSPB6
|
heat shock protein, alpha-crystallin-related, B6 |
chr4_-_186456766 | 1.67 |
ENST00000284771.6
|
PDLIM3
|
PDZ and LIM domain 3 |
chr17_+_72426891 | 1.67 |
ENST00000392627.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr19_+_44084696 | 1.67 |
ENST00000562255.1
ENST00000569031.2 |
PINLYP
|
phospholipase A2 inhibitor and LY6/PLAUR domain containing |
chr20_-_18038521 | 1.66 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
chr19_-_36643329 | 1.66 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
chr4_+_106816644 | 1.66 |
ENST00000506666.1
ENST00000503451.1 |
NPNT
|
nephronectin |
chr6_-_31846744 | 1.65 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr14_-_21270995 | 1.65 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
chrX_-_110513703 | 1.64 |
ENST00000324068.1
|
CAPN6
|
calpain 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.4 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
2.2 | 6.6 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
1.8 | 1.8 | GO:0007616 | long-term memory(GO:0007616) |
1.7 | 6.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
1.5 | 6.2 | GO:0097195 | pilomotor reflex(GO:0097195) |
1.4 | 4.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
1.3 | 5.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
1.3 | 4.0 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
1.3 | 4.0 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
1.3 | 2.6 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
1.3 | 5.0 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.2 | 4.9 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
1.2 | 3.6 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.2 | 5.9 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.2 | 6.9 | GO:0061760 | antifungal innate immune response(GO:0061760) |
1.2 | 6.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
1.1 | 3.4 | GO:0010877 | lipid transport involved in lipid storage(GO:0010877) |
1.1 | 9.7 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
1.1 | 3.2 | GO:0001868 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
1.1 | 5.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
1.1 | 6.3 | GO:0030421 | defecation(GO:0030421) |
1.0 | 4.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
1.0 | 5.7 | GO:0070295 | renal water absorption(GO:0070295) |
1.0 | 13.3 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 4.7 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.9 | 7.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.9 | 3.8 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.9 | 3.8 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.9 | 2.8 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.9 | 3.7 | GO:0032771 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.9 | 5.5 | GO:0009804 | coumarin metabolic process(GO:0009804) |
0.9 | 4.5 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.9 | 1.8 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.9 | 2.6 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.9 | 7.7 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
0.8 | 4.9 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.8 | 4.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 3.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 0.8 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 3.9 | GO:0072244 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.8 | 1.5 | GO:0036022 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
0.8 | 4.6 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.8 | 5.4 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.8 | 1.5 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
0.8 | 3.0 | GO:0009956 | radial pattern formation(GO:0009956) |
0.8 | 2.3 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.7 | 7.5 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.7 | 2.2 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.7 | 2.9 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.7 | 2.2 | GO:0051040 | regulation of calcium-independent cell-cell adhesion(GO:0051040) |
0.7 | 0.7 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.7 | 2.2 | GO:1903717 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.7 | 2.2 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.7 | 5.7 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.7 | 3.6 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.7 | 4.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
0.7 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.7 | 0.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.7 | 6.2 | GO:0036017 | response to erythropoietin(GO:0036017) |
0.7 | 0.7 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.7 | 10.8 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.7 | 5.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.7 | 2.7 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.7 | 2.7 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.7 | 1.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.7 | 2.0 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
0.7 | 2.0 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.7 | 2.0 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.6 | 1.3 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.6 | 12.7 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.6 | 1.9 | GO:0071676 | negative regulation of mononuclear cell migration(GO:0071676) |
0.6 | 1.9 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
0.6 | 1.9 | GO:0060827 | regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060827) negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
0.6 | 3.7 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 3.1 | GO:1905040 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.6 | 1.8 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.6 | 0.6 | GO:0043583 | ear development(GO:0043583) |
0.6 | 4.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.6 | 4.9 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.6 | 1.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 0.6 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.6 | 3.6 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.6 | 1.2 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.6 | 4.8 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.6 | 1.8 | GO:0021919 | BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
0.6 | 0.6 | GO:0090066 | regulation of anatomical structure size(GO:0090066) |
0.6 | 4.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.6 | 1.8 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.6 | 2.3 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.6 | 1.7 | GO:0048627 | myoblast development(GO:0048627) |
0.6 | 10.4 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.6 | 3.4 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.6 | 2.9 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.6 | 1.7 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.6 | 1.7 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.6 | 3.9 | GO:0008218 | bioluminescence(GO:0008218) |
0.6 | 3.3 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.6 | 3.3 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.6 | 3.3 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.6 | 3.3 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.6 | 3.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.5 | 1.6 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.5 | 1.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 18.2 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.5 | 1.6 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.5 | 3.7 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.5 | 1.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.5 | 1.6 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.5 | 3.2 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.5 | 2.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.5 | 1.6 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.5 | 3.6 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.5 | 1.0 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.5 | 2.5 | GO:0060214 | endocardium formation(GO:0060214) |
0.5 | 5.0 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.5 | 7.0 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.5 | 6.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.5 | 2.0 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.5 | 2.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 2.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.5 | 2.9 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.5 | 2.9 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.5 | 1.5 | GO:0034442 | regulation of lipoprotein oxidation(GO:0034442) |
0.5 | 0.5 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.5 | 1.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.5 | 1.0 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.5 | 1.4 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.5 | 0.5 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.5 | 2.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.5 | 0.5 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.5 | 1.4 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.5 | 4.6 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 1.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.5 | 5.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.5 | 1.4 | GO:0007412 | axon target recognition(GO:0007412) |
0.5 | 0.9 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.5 | 0.9 | GO:2000722 | regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.5 | 1.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 0.9 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.4 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.4 | 1.3 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.4 | 0.9 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.4 | 0.4 | GO:0016487 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
0.4 | 8.8 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 2.2 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.4 | 4.4 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.4 | 1.7 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.4 | 68.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 1.7 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.4 | 2.1 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.4 | 2.6 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.4 | 1.3 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.4 | 0.8 | GO:0060775 | mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
0.4 | 2.1 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 2.5 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.4 | 2.9 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.4 | 0.4 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.4 | 0.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.4 | 1.6 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.4 | 1.2 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.4 | 0.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.4 | 1.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 0.4 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
0.4 | 0.8 | GO:0061551 | trigeminal ganglion development(GO:0061551) |
0.4 | 3.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.4 | 3.6 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.4 | 2.0 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.4 | 1.6 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 1.2 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.4 | 0.8 | GO:0044691 | tooth eruption(GO:0044691) |
0.4 | 1.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.2 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.4 | 2.0 | GO:0060056 | mammary gland involution(GO:0060056) |
0.4 | 1.2 | GO:1990910 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
0.4 | 4.3 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.4 | 1.9 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.4 | 1.5 | GO:0001971 | negative regulation of activation of membrane attack complex(GO:0001971) |
0.4 | 1.5 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.4 | 8.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.4 | 1.5 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 2.3 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 0.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.4 | 0.7 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.4 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.4 | 0.7 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.4 | 1.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.4 | 0.4 | GO:0001824 | blastocyst development(GO:0001824) |
0.4 | 1.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.4 | 4.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 3.3 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 1.1 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.4 | 0.4 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.4 | 1.5 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.4 | 0.7 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.4 | 0.7 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.4 | 1.4 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.4 | 0.4 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 1.8 | GO:0018153 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.4 | 1.8 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.4 | 1.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.4 | 0.4 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.4 | 0.7 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.4 | 1.1 | GO:0097325 | melanocyte proliferation(GO:0097325) melanocyte apoptotic process(GO:1902362) |
0.4 | 1.4 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.3 | 0.3 | GO:0035038 | female pronucleus assembly(GO:0035038) |
0.3 | 1.4 | GO:0018277 | protein deamination(GO:0018277) |
0.3 | 8.0 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.3 | 1.0 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 0.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.3 | 1.4 | GO:0038185 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.3 | 0.3 | GO:0070873 | regulation of glycogen metabolic process(GO:0070873) |
0.3 | 2.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.3 | 1.0 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.3 | 0.7 | GO:0048668 | collateral sprouting(GO:0048668) |
0.3 | 2.0 | GO:0001757 | somite specification(GO:0001757) |
0.3 | 3.3 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.7 | GO:1904640 | response to methionine(GO:1904640) |
0.3 | 2.0 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
0.3 | 0.3 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.3 | 1.3 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
0.3 | 0.3 | GO:0072190 | primary prostatic bud elongation(GO:0060516) ureter urothelium development(GO:0072190) ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) |
0.3 | 1.0 | GO:0060345 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.3 | 0.3 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.3 | 1.0 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.3 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 1.0 | GO:0044335 | canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
0.3 | 2.9 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.3 | 1.0 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.3 | 2.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.3 | 1.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.3 | 1.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.3 | 0.3 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 5.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.3 | 0.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.3 | 3.2 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.3 | 0.6 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.3 | 4.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.3 | 2.5 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.3 | 1.6 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 1.5 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
0.3 | 0.3 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.3 | 1.2 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.3 | 2.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.3 | 0.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.3 | 0.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.3 | 3.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 0.3 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.3 | 1.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.9 | GO:0016115 | diterpenoid catabolic process(GO:0016103) terpenoid catabolic process(GO:0016115) retinoic acid catabolic process(GO:0034653) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 1.5 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.3 | 0.6 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.3 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.3 | 0.9 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.3 | 0.9 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.3 | 0.3 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) |
0.3 | 4.1 | GO:0015705 | iodide transport(GO:0015705) |
0.3 | 2.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 2.7 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 0.9 | GO:0031247 | actin rod assembly(GO:0031247) |
0.3 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 0.9 | GO:0008052 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.3 | 1.5 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.3 | 0.3 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.9 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.3 | 1.2 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 0.9 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.9 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
0.3 | 1.4 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.3 | 3.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.3 | 2.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.3 | 0.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.3 | 0.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.3 | 2.8 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 0.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.3 | 1.7 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.3 | 1.1 | GO:0034238 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
0.3 | 0.9 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.3 | 1.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.3 | 1.1 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.3 | 0.3 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 0.3 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.3 | 1.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 1.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.3 | 1.7 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.3 | 1.4 | GO:0002778 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.3 | 1.9 | GO:0016264 | gap junction assembly(GO:0016264) |
0.3 | 0.6 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.3 | 1.4 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.3 | 3.9 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 1.9 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.3 | 0.5 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.3 | 3.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.3 | 1.6 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.3 | 0.3 | GO:1903413 | cellular response to bile acid(GO:1903413) |
0.3 | 0.8 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.3 | 0.3 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) regulation of determination of dorsal identity(GO:2000015) |
0.3 | 0.8 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.3 | 0.8 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 1.3 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 5.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.3 | 3.0 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.3 | 0.8 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.3 | 2.1 | GO:0044268 | multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) |
0.3 | 0.5 | GO:0009133 | nucleoside diphosphate biosynthetic process(GO:0009133) |
0.3 | 0.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 0.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.3 | 4.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 1.1 | GO:0035425 | autocrine signaling(GO:0035425) |
0.3 | 0.8 | GO:2000302 | positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 | 1.3 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.5 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.3 | 0.8 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.3 | 1.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 8.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.3 | 2.6 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.3 | 0.3 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
0.3 | 1.0 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.3 | 2.1 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.3 | 0.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 0.5 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.3 | 0.5 | GO:0032431 | positive regulation of phospholipase A2 activity(GO:0032430) activation of phospholipase A2 activity(GO:0032431) |
0.3 | 0.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.3 | 1.3 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.3 | 0.5 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 3.0 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 1.2 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.2 | 0.2 | GO:0038001 | paracrine signaling(GO:0038001) |
0.2 | 0.5 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.7 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 15.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.2 | 5.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.2 | 1.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 1.5 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.2 | 1.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 3.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.2 | 1.0 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
0.2 | 1.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.2 | 2.4 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.2 | 1.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.2 | 3.4 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.2 | 1.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 2.1 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 16.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.2 | 0.2 | GO:0045777 | positive regulation of blood pressure(GO:0045777) |
0.2 | 3.8 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 0.7 | GO:0035803 | egg coat formation(GO:0035803) |
0.2 | 0.7 | GO:0048749 | compound eye development(GO:0048749) |
0.2 | 0.2 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 0.9 | GO:0048371 | lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
0.2 | 0.5 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
0.2 | 2.3 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.2 | 0.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.2 | 1.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.2 | 0.5 | GO:0006554 | lysine catabolic process(GO:0006554) |
0.2 | 7.2 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.7 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.2 | 1.4 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 1.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.2 | 3.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.2 | GO:0071231 | cellular response to folic acid(GO:0071231) |
0.2 | 0.5 | GO:0016322 | neuron remodeling(GO:0016322) |
0.2 | 1.4 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.5 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.2 | 2.3 | GO:0002159 | desmosome assembly(GO:0002159) |
0.2 | 0.7 | GO:0019516 | lactate oxidation(GO:0019516) |
0.2 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
0.2 | 1.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.2 | 0.4 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.2 | 2.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 0.9 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
0.2 | 1.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.2 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.2 | 1.5 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.2 | 0.2 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
0.2 | 1.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.9 | GO:1904199 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.2 | 0.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.2 | 0.7 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.2 | 1.9 | GO:0098743 | cell aggregation(GO:0098743) |
0.2 | 1.5 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.2 | 1.1 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.2 | 0.2 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.2 | 4.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.8 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
0.2 | 0.6 | GO:0035106 | operant conditioning(GO:0035106) |
0.2 | 0.6 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.2 | 0.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 | 0.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 0.8 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.2 | 0.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.2 | 3.5 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.2 | 0.6 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.2 | 0.6 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
0.2 | 1.2 | GO:0099538 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.2 | 4.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.2 | 0.2 | GO:1901532 | regulation of hematopoietic progenitor cell differentiation(GO:1901532) |
0.2 | 0.2 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
0.2 | 0.4 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.2 | 0.4 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.2 | 0.8 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.2 | 1.0 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.2 | 0.2 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.4 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.2 | 1.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.2 | 1.4 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.4 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.6 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.2 | 0.6 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.2 | 2.4 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.2 | 1.4 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.2 | 1.2 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.2 | 0.4 | GO:0034440 | lipid oxidation(GO:0034440) |
0.2 | 0.8 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.2 | 0.2 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.2 | 0.8 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
0.2 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.2 | 0.4 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.2 | 1.0 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 3.9 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.2 | 1.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.2 | 0.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 0.4 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.2 | 1.8 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 0.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
0.2 | 1.2 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 0.6 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.2 | 0.6 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.2 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.2 | 3.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 0.8 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
0.2 | 6.4 | GO:0033622 | integrin activation(GO:0033622) |
0.2 | 0.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.8 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
0.2 | 0.8 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.6 | GO:0090031 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) positive regulation of steroid hormone biosynthetic process(GO:0090031) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.2 | 4.4 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.2 | 3.5 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.2 | 3.0 | GO:0060180 | female mating behavior(GO:0060180) |
0.2 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 0.8 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.2 | 1.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.2 | 0.8 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.2 | 0.8 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.2 | 0.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.2 | 0.8 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.2 | 1.5 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.2 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 3.4 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 0.9 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.2 | 0.7 | GO:0003335 | corneocyte development(GO:0003335) |
0.2 | 1.3 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.2 | 6.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.9 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.2 | 2.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.2 | 0.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 0.2 | GO:0060166 | olfactory pit development(GO:0060166) |
0.2 | 0.4 | GO:1903365 | regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
0.2 | 0.5 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.2 | 1.4 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.2 | 0.5 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.2 | 1.6 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.5 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.2 | 0.2 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 7.5 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 3.8 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.7 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.9 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.2 | 1.8 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 1.2 | GO:0038084 | vascular endothelial growth factor signaling pathway(GO:0038084) |
0.2 | 2.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 0.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 1.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 4.4 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 1.1 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) paramesonephric duct development(GO:0061205) |
0.2 | 0.7 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.7 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 1.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.7 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 1.0 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.2 | 0.5 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.2 | 1.0 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
0.2 | 0.7 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.2 | 0.5 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.2 | 0.8 | GO:0035864 | response to potassium ion(GO:0035864) |
0.2 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.2 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 0.3 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.2 | 1.3 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 1.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.2 | 0.8 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 0.5 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
0.2 | 0.5 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.2 | 1.0 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 0.5 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.2 | 0.3 | GO:1903207 | detoxification of copper ion(GO:0010273) neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) detoxification of mercury ion(GO:0050787) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) stress response to copper ion(GO:1990169) regulation of cellular amino acid biosynthetic process(GO:2000282) |
0.2 | 0.8 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.2 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.5 | GO:0034436 | glycoprotein transport(GO:0034436) |
0.2 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 0.7 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 0.3 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.2 | 4.0 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.2 | 1.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 0.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.2 | 1.0 | GO:0003158 | endothelium development(GO:0003158) |
0.2 | 0.2 | GO:0061009 | common bile duct development(GO:0061009) |
0.2 | 0.5 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.2 | 2.1 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.2 | 0.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.2 | 0.6 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 1.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.0 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.2 | 1.3 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.2 | 2.2 | GO:0035878 | nail development(GO:0035878) |
0.2 | 0.3 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
0.2 | 0.5 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.2 | 0.5 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.2 | 1.6 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.2 | 1.2 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.2 | 2.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.5 | GO:0060179 | male mating behavior(GO:0060179) |
0.2 | 0.6 | GO:0014806 | smooth muscle hyperplasia(GO:0014806) |
0.2 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.2 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 1.8 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 0.2 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.2 | 0.5 | GO:0003016 | respiratory system process(GO:0003016) |
0.2 | 0.6 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
0.2 | 0.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.2 | 1.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 2.1 | GO:0015886 | heme transport(GO:0015886) |
0.2 | 1.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.2 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 0.8 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.1 | 0.9 | GO:0001890 | placenta development(GO:0001890) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 3.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.7 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.2 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.6 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 1.5 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 1.3 | GO:0016102 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 0.6 | GO:0048675 | axon extension(GO:0048675) |
0.1 | 1.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.7 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.1 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.3 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.9 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.1 | 0.9 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.4 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.1 | 3.2 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 1.4 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 4.6 | GO:0002076 | osteoblast development(GO:0002076) |
0.1 | 6.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.1 | 0.7 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.1 | 0.1 | GO:2001021 | negative regulation of response to DNA damage stimulus(GO:2001021) |
0.1 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
0.1 | 3.1 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.4 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.1 | 0.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.1 | 0.6 | GO:0090119 | vesicle-mediated cholesterol transport(GO:0090119) |
0.1 | 0.7 | GO:0044789 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.1 | 1.1 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.1 | 0.7 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.1 | 0.6 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 5.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 2.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 2.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.1 | 0.4 | GO:0086029 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.1 | 3.4 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.1 | 2.1 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.1 | 1.6 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.1 | 0.1 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
0.1 | 0.4 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 0.7 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.1 | 0.5 | GO:0009386 | translational attenuation(GO:0009386) |
0.1 | 0.4 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.1 | 0.5 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.1 | 0.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
0.1 | 0.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.1 | 1.9 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.1 | 0.9 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.1 | GO:2001269 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.1 | 1.6 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
0.1 | 0.8 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.4 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.1 | 0.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 1.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.3 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.1 | 0.4 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.1 | 0.6 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 1.4 | GO:0035791 | platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
0.1 | 2.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 0.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.1 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 5.6 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.6 | GO:0030073 | insulin secretion(GO:0030073) |
0.1 | 1.0 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.1 | 2.3 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 5.1 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 12.3 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.1 | 0.4 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.1 | 2.9 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 1.6 | GO:0007351 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 2.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.6 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.1 | 0.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.1 | 0.2 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.1 | 1.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 8.4 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.2 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 | 3.0 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.9 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.5 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.4 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:1904761 | negative regulation of myofibroblast differentiation(GO:1904761) |
0.1 | 16.8 | GO:0070268 | cornification(GO:0070268) |
0.1 | 4.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 2.5 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.1 | 0.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.1 | 2.7 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 2.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.1 | 1.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0032222 | regulation of synaptic transmission, cholinergic(GO:0032222) |
0.1 | 0.6 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 2.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.1 | 0.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 1.3 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.6 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 0.2 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.1 | 0.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.1 | 0.4 | GO:1903412 | response to bile acid(GO:1903412) |
0.1 | 0.4 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.1 | 2.4 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 7.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 1.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 0.5 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.1 | 1.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.5 | GO:1905225 | thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) response to thyrotropin-releasing hormone(GO:1905225) cellular response to thyrotropin-releasing hormone(GO:1905229) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.3 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 1.3 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.1 | GO:0031116 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) positive regulation of microtubule polymerization(GO:0031116) |
0.1 | 0.3 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.1 | 0.7 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.1 | 0.7 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 2.8 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 3.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 1.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 1.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 5.0 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.8 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.7 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 1.1 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.6 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.1 | 1.2 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.1 | 1.5 | GO:0098868 | bone growth(GO:0098868) |
0.1 | 0.1 | GO:0014717 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
0.1 | 0.9 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.1 | 0.3 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
0.1 | 0.3 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
0.1 | 1.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.3 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.1 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.1 | 0.3 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
0.1 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 1.6 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 0.9 | GO:0051017 | actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
0.1 | 1.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 1.6 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 3.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.4 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 2.2 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.1 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.1 | 2.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.5 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 1.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.1 | 1.1 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.1 | 0.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 0.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 1.4 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.3 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.1 | 0.4 | GO:0046928 | regulation of neurotransmitter secretion(GO:0046928) regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.4 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 1.8 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.7 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 1.6 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 2.0 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 16.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 2.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 1.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 2.0 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.1 | 0.5 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
0.1 | 1.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.1 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 1.0 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.2 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.1 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.1 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.1 | 1.0 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.1 | 0.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 0.1 | GO:0044209 | AMP salvage(GO:0044209) |
0.1 | 0.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
0.1 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 0.7 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.3 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
0.1 | 0.1 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.1 | 0.1 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.1 | 1.2 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.1 | 0.3 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 0.2 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.1 | 0.1 | GO:0034059 | response to anoxia(GO:0034059) |
0.1 | 1.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 1.0 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.4 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.1 | 0.5 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.1 | 0.9 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 1.1 | GO:0071711 | basement membrane organization(GO:0071711) |
0.1 | 0.4 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.1 | 0.3 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 5.5 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 0.6 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.4 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.1 | 0.7 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.4 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.1 | 0.4 | GO:0032218 | riboflavin transport(GO:0032218) |
0.1 | 0.1 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.1 | 0.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.8 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.1 | 0.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:1903020 | positive regulation of glycoprotein metabolic process(GO:1903020) |
0.1 | 0.3 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 2.6 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 0.9 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.6 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 2.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 0.2 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.1 | GO:0032070 | regulation of deoxyribonuclease activity(GO:0032070) |
0.1 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.1 | GO:0033632 | negative regulation of extracellular matrix disassembly(GO:0010716) regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.1 | 1.4 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 1.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.2 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.1 | 0.2 | GO:0046543 | development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
0.1 | 0.5 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.3 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.2 | GO:2000395 | regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.2 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.4 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 0.6 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.5 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.1 | 0.7 | GO:0031639 | plasminogen activation(GO:0031639) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.9 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.2 | GO:0042441 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.1 | 0.3 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.1 | 0.6 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.5 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.1 | 0.2 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.4 | GO:0044003 | modification by symbiont of host morphology or physiology(GO:0044003) |
0.1 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 0.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.1 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.5 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.4 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.3 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.1 | 0.3 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.4 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.1 | GO:0097205 | glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
0.1 | 0.3 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.1 | 0.1 | GO:0032527 | protein exit from endoplasmic reticulum(GO:0032527) |
0.1 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 3.2 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.3 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.1 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.1 | 0.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.8 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.1 | 0.2 | GO:0071790 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.1 | 0.9 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.1 | 0.4 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.1 | 0.1 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 1.0 | GO:0001893 | maternal placenta development(GO:0001893) |
0.1 | 1.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.1 | 0.2 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.1 | 1.1 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.1 | 1.2 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.4 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.1 | 0.9 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.1 | GO:0061213 | positive regulation of mesonephros development(GO:0061213) |
0.1 | 0.8 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.1 | 0.1 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.3 | GO:0016259 | selenocysteine metabolic process(GO:0016259) |
0.1 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 1.8 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.3 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.5 | GO:2000741 | mesenchymal stem cell differentiation(GO:0072497) regulation of mesenchymal stem cell differentiation(GO:2000739) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.4 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.1 | 2.0 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.1 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.2 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.1 | 0.2 | GO:0046218 | tryptophan catabolic process(GO:0006569) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.1 | 0.5 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.3 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.1 | 0.4 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.3 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.1 | 2.5 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 2.4 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.1 | 0.3 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.1 | 0.7 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.1 | 0.3 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.6 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.1 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.1 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.1 | 0.8 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.9 | GO:0001709 | cell fate determination(GO:0001709) |
0.1 | 0.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.1 | 0.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.3 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.1 | 0.3 | GO:0072131 | kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) |
0.1 | 0.1 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.1 | GO:0046460 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.1 | 0.1 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.1 | 0.1 | GO:1903423 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.3 | GO:0043335 | protein unfolding(GO:0043335) |
0.1 | 0.1 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.1 | 1.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.4 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
0.1 | 0.4 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 1.5 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
0.1 | 0.2 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.1 | 0.1 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.1 | 0.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 0.2 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.1 | 0.1 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.7 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.1 | 0.7 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.4 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.1 | 0.1 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 0.6 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.1 | 0.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.3 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 1.2 | GO:0031076 | embryonic camera-type eye development(GO:0031076) |
0.1 | 0.2 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.1 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.4 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.2 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.1 | 0.6 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.1 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.2 | GO:0072106 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.1 | 0.4 | GO:0030728 | ovulation(GO:0030728) |
0.1 | 0.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.8 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.1 | 0.4 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 0.5 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
0.1 | 0.2 | GO:0086027 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.4 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.8 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 5.6 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.1 | 0.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
0.1 | 0.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 1.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
0.1 | 0.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 1.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.1 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.1 | GO:0060421 | positive regulation of heart growth(GO:0060421) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.6 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.5 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.1 | 0.9 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.3 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.1 | 0.1 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.1 | 0.8 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.5 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.1 | 3.1 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.1 | 0.1 | GO:0048550 | negative regulation of pinocytosis(GO:0048550) |
0.1 | 0.3 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.3 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 0.1 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.1 | 0.2 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.0 | 0.0 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
0.0 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.0 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.7 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.0 | 1.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.0 | 0.1 | GO:0048332 | mesoderm formation(GO:0001707) mesoderm morphogenesis(GO:0048332) |
0.0 | 0.7 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.0 | 0.0 | GO:0043200 | response to amino acid(GO:0043200) |
0.0 | 0.6 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.0 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.0 | 0.1 | GO:1904044 | response to aldosterone(GO:1904044) |
0.0 | 0.2 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.0 | 0.2 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.3 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.4 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.2 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.0 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.4 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.0 | 0.0 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.0 | 0.4 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.0 | 0.2 | GO:0019627 | urea metabolic process(GO:0019627) |
0.0 | 0.0 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.0 | 0.0 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.0 | 2.3 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.0 | 0.1 | GO:0070230 | positive regulation of lymphocyte apoptotic process(GO:0070230) |
0.0 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 2.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 0.1 | GO:1901252 | modulation by host of viral RNA genome replication(GO:0044830) regulation of intracellular transport of viral material(GO:1901252) positive regulation of intracellular transport of viral material(GO:1901254) |
0.0 | 0.4 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.0 | 0.1 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.0 | 0.2 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.0 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.0 | 0.1 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.1 | GO:0060068 | vagina development(GO:0060068) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.0 | 0.8 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.0 | 0.2 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.0 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.5 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.1 | GO:0051031 | tRNA transport(GO:0051031) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.1 | GO:1902416 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
0.0 | 10.0 | GO:0030198 | extracellular matrix organization(GO:0030198) |
0.0 | 0.3 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.2 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.1 | GO:0018011 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 1.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
0.0 | 0.0 | GO:0051971 | positive regulation of transmission of nerve impulse(GO:0051971) |
0.0 | 1.1 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
0.0 | 0.4 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.0 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.5 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.0 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.0 | 0.1 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.0 | 0.1 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.6 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.0 | 0.5 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.6 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.0 | 0.0 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.0 | 0.1 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.0 | 0.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
0.0 | 0.0 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.9 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 1.5 | GO:1901998 | toxin transport(GO:1901998) |
0.0 | 0.2 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.1 | GO:1903299 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.0 | 0.4 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.0 | 0.2 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.1 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.0 | 0.1 | GO:0007296 | vitellogenesis(GO:0007296) |
0.0 | 0.1 | GO:0032262 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
0.0 | 0.1 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.0 | 0.9 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.0 | 0.9 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.0 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.9 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.2 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.0 | 0.6 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.0 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.3 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.0 | 0.0 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.0 | 0.0 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.1 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.0 | 0.1 | GO:0032324 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.0 | 0.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.4 | GO:0006828 | manganese ion transport(GO:0006828) |
0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.0 | 0.0 | GO:2000479 | regulation of cAMP-dependent protein kinase activity(GO:2000479) |
0.0 | 0.0 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.0 | 0.1 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.0 | 0.2 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.2 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.0 | 0.3 | GO:0043090 | amino acid import(GO:0043090) |
0.0 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.0 | 0.0 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.0 | 0.5 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.0 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.5 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.1 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.0 | 0.1 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.0 | 0.5 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.0 | 1.0 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.0 | 0.2 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.0 | 1.0 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.0 | 0.1 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.0 | 0.2 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.2 | GO:0015811 | L-cystine transport(GO:0015811) |
0.0 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:1990403 | embryonic brain development(GO:1990403) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.3 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.0 | 0.1 | GO:0072017 | distal tubule development(GO:0072017) |
0.0 | 0.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.0 | 0.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.0 | 0.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.0 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.0 | 0.2 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.5 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.8 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.0 | 0.1 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.0 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.0 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.0 | 0.2 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.3 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.0 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
0.0 | 0.1 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.1 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.0 | 0.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.0 | 0.0 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.0 | 0.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.0 | 1.1 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.1 | GO:0000098 | sulfur amino acid catabolic process(GO:0000098) |
0.0 | 0.1 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.0 | 0.2 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.0 | 0.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.2 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.0 | 0.2 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.4 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.0 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.0 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.1 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.2 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.3 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.0 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
0.0 | 0.0 | GO:1903427 | negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.0 | 0.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.3 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.0 | 0.1 | GO:0045687 | regulation of glial cell differentiation(GO:0045685) positive regulation of glial cell differentiation(GO:0045687) |
0.0 | 0.3 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.0 | 0.0 | GO:0021539 | subthalamus development(GO:0021539) |
0.0 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.0 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.0 | 0.1 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.0 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.1 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.1 | GO:0098761 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.0 | 0.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0060281 | regulation of oocyte development(GO:0060281) |
0.0 | 0.1 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.2 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.0 | 0.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.3 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 0.3 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
0.0 | 0.1 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.0 | 0.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.0 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.0 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.0 | 0.0 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.0 | 0.1 | GO:0030031 | cell projection assembly(GO:0030031) |
0.0 | 0.1 | GO:0043491 | protein kinase B signaling(GO:0043491) |
0.0 | 0.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.0 | 0.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.0 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.0 | 0.5 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 1.1 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.0 | 0.1 | GO:0001501 | skeletal system development(GO:0001501) |
0.0 | 0.0 | GO:2000105 | regulation of nuclear cell cycle DNA replication(GO:0033262) positive regulation of DNA-dependent DNA replication(GO:2000105) |
0.0 | 0.1 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.0 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.0 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.0 | GO:0071139 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.0 | 0.5 | GO:0031016 | pancreas development(GO:0031016) |
0.0 | 0.0 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
0.0 | 0.3 | GO:0070841 | inclusion body assembly(GO:0070841) |
0.0 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.0 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.0 | 0.1 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.0 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.1 | GO:0015893 | drug transport(GO:0015893) |
0.0 | 0.1 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.0 | 0.0 | GO:0006272 | leading strand elongation(GO:0006272) |
0.0 | 0.0 | GO:0060992 | response to fungicide(GO:0060992) |
0.0 | 0.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.0 | 0.4 | GO:0051216 | cartilage development(GO:0051216) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.2 | GO:0005584 | collagen type I trimer(GO:0005584) |
1.3 | 6.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
1.1 | 5.5 | GO:0030934 | anchoring collagen complex(GO:0030934) |
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
1.0 | 6.7 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
1.0 | 5.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 10.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 2.7 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.8 | 2.5 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.8 | 2.5 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.8 | 7.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.8 | 8.8 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.8 | 13.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.8 | 3.0 | GO:0045160 | myosin I complex(GO:0045160) |
0.8 | 18.8 | GO:0042627 | chylomicron(GO:0042627) |
0.7 | 8.7 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.7 | 0.7 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.7 | 0.7 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
0.7 | 3.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.7 | 2.0 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.7 | 26.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 1.9 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.6 | 1.9 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.6 | 1.8 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.6 | 6.5 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.6 | 6.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 8.3 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.6 | 0.6 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
0.5 | 1.6 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 1.5 | GO:1990032 | parallel fiber(GO:1990032) |
0.5 | 4.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.5 | 4.5 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) complex of collagen trimers(GO:0098644) |
0.5 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.5 | 15.1 | GO:0005614 | interstitial matrix(GO:0005614) |
0.4 | 2.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.4 | 2.2 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.4 | 0.4 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.4 | 3.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.4 | 14.4 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.4 | 13.5 | GO:0005605 | basal lamina(GO:0005605) |
0.4 | 13.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.4 | 8.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 1.2 | GO:0001534 | radial spoke(GO:0001534) |
0.4 | 3.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.4 | 3.1 | GO:1990393 | 3M complex(GO:1990393) |
0.4 | 2.7 | GO:0071437 | invadopodium(GO:0071437) |
0.4 | 1.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.4 | 1.8 | GO:0032449 | CBM complex(GO:0032449) |
0.4 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 1.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.3 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 1.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.3 | 8.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.3 | 1.0 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.3 | 1.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.3 | 16.7 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 7.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 0.3 | GO:0044393 | microspike(GO:0044393) |
0.3 | 0.3 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.3 | 2.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.3 | 29.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.3 | 0.9 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.3 | 1.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.5 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 26.2 | GO:0005604 | basement membrane(GO:0005604) |
0.3 | 1.6 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.3 | 2.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 1.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.3 | 48.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.3 | 2.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.2 | 6.9 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 0.2 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.2 | 2.2 | GO:0008305 | integrin complex(GO:0008305) |
0.2 | 2.4 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.7 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.2 | 1.4 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.2 | 8.0 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 2.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 0.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.2 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.2 | 7.4 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 3.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 1.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 0.6 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.2 | 1.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 1.0 | GO:0005687 | U4 snRNP(GO:0005687) |
0.2 | 1.4 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.2 | 0.6 | GO:0097134 | Y chromosome(GO:0000806) cyclin E1-CDK2 complex(GO:0097134) |
0.2 | 2.5 | GO:0097433 | dense body(GO:0097433) |
0.2 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.2 | 1.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.2 | 0.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 1.7 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 2.4 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 6.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 3.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 2.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.2 | 0.2 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.2 | 0.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.2 | 1.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 0.5 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.2 | 2.0 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.1 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.9 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 5.2 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.6 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.1 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 1.0 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 14.4 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 18.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.5 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.9 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 2.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 40.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 38.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 1.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 11.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.4 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.1 | 1.3 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 9.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 17.3 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 4.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.4 | GO:0000438 | core TFIIH complex portion of holo TFIIH complex(GO:0000438) |
0.1 | 2.2 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.6 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.8 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.1 | 1.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 2.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 3.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 13.4 | GO:0032432 | actin filament bundle(GO:0032432) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.2 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 4.2 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.4 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.1 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.1 | 2.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.1 | 21.1 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.3 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 4.5 | GO:0005903 | brush border(GO:0005903) |
0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.1 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 1.6 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.3 | GO:0033011 | perinuclear theca(GO:0033011) |
0.1 | 1.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 16.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.1 | 2.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 120.5 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 1.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 2.8 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.8 | GO:0032421 | stereocilium bundle(GO:0032421) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.9 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.1 | 0.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 1.7 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 4.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.1 | 0.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.1 | 0.4 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.5 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.1 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 0.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.5 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 0.3 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.6 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 1.2 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 2.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.4 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.6 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.4 | GO:0005652 | nuclear lamina(GO:0005652) |
0.1 | 0.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 1.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 4.4 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 0.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.1 | 3.6 | GO:0005901 | caveola(GO:0005901) |
0.1 | 1.4 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.4 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 0.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 0.4 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.0 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 5.9 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 4.0 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.0 | 1.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 0.7 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.1 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.0 | 1.1 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.3 | GO:0098536 | deuterosome(GO:0098536) |
0.0 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.7 | GO:0036038 | MKS complex(GO:0036038) |
0.0 | 0.5 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.1 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 1.0 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.5 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.1 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 0.1 | GO:0071010 | prespliceosome(GO:0071010) |
0.0 | 1.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.0 | 0.4 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 1.0 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.5 | GO:0070161 | anchoring junction(GO:0070161) |
0.0 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.0 | 0.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.0 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.2 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.3 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 1.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 17.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.3 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.2 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.1 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.0 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.3 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.1 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.0 | 0.6 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.1 | GO:0097486 | late endosome lumen(GO:0031906) multivesicular body lumen(GO:0097486) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.1 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.1 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 0.1 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.0 | 0.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 5.6 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.0 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.1 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:1990037 | Lewy body core(GO:1990037) |
0.0 | 0.1 | GO:0097196 | Shu complex(GO:0097196) |
0.0 | 0.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.0 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.9 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.0 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 6.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 6.7 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 28.5 | GO:0070062 | extracellular exosome(GO:0070062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 12.0 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
2.2 | 4.3 | GO:0008430 | selenium binding(GO:0008430) |
1.6 | 4.8 | GO:0005055 | laminin receptor activity(GO:0005055) |
1.5 | 4.6 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
1.5 | 14.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
1.3 | 6.7 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
1.3 | 2.6 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
1.1 | 4.2 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.1 | 4.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
1.0 | 6.2 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 4.1 | GO:1904492 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
1.0 | 6.7 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.9 | 2.8 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
0.9 | 2.8 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.9 | 2.8 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.9 | 4.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.9 | 1.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.9 | 5.2 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.9 | 2.6 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.9 | 2.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.8 | 3.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.8 | 4.1 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.8 | 5.7 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.8 | 3.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.8 | 3.2 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.8 | 2.3 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.8 | 3.8 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.8 | 3.0 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.7 | 2.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.7 | 2.2 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.7 | 8.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 7.9 | GO:0046790 | virion binding(GO:0046790) |
0.7 | 6.3 | GO:0032810 | sterol response element binding(GO:0032810) |
0.7 | 2.1 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.7 | 5.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.7 | 2.0 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.7 | 9.1 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.6 | 3.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.6 | 2.6 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.6 | 5.7 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.6 | 1.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 2.5 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.6 | 0.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 1.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 3.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.6 | 4.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.6 | 2.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.6 | 2.3 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
0.6 | 2.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.6 | 1.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.6 | 7.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 0.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.6 | 10.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 3.3 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.5 | 1.6 | GO:0004938 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.5 | 1.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.5 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 2.1 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.5 | 1.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.5 | 2.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.5 | 0.5 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.5 | 4.6 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.5 | 2.1 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.5 | 2.0 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.5 | 2.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 2.9 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 1.9 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 0.5 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
0.5 | 1.9 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.5 | 1.4 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
0.5 | 2.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.5 | 2.7 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 3.1 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.4 | 1.8 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.4 | 0.4 | GO:0047718 | geranylgeranyl reductase activity(GO:0045550) indanol dehydrogenase activity(GO:0047718) |
0.4 | 1.3 | GO:0019115 | benzaldehyde dehydrogenase activity(GO:0019115) |
0.4 | 1.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.4 | 1.3 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
0.4 | 3.8 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.4 | 3.8 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.4 | 1.3 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.4 | 1.7 | GO:0035939 | microsatellite binding(GO:0035939) |
0.4 | 2.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.4 | 7.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.4 | 1.6 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.4 | 1.6 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 2.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 19.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.4 | 1.2 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.4 | 5.4 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.4 | 1.2 | GO:0050577 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.4 | 1.5 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.4 | 2.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.4 | 2.6 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.4 | 4.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.4 | 1.1 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
0.4 | 1.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.4 | 2.9 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 1.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.4 | 1.8 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.4 | 8.6 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.4 | 3.2 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.4 | 8.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 1.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 46.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 2.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.3 | 1.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.3 | 1.0 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.3 | 1.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 12.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.3 | 2.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.3 | 1.4 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.3 | 4.1 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 2.4 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.3 | 2.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.3 | 1.0 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.3 | 1.3 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.3 | 1.0 | GO:0097689 | iron channel activity(GO:0097689) |
0.3 | 2.0 | GO:0016213 | linoleoyl-CoA desaturase activity(GO:0016213) |
0.3 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 1.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 0.7 | GO:0051379 | epinephrine binding(GO:0051379) |
0.3 | 1.0 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.3 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.3 | 0.6 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 3.2 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.3 | 2.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 0.9 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 1.6 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.3 | 2.2 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.3 | 4.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 0.3 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 5.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 1.2 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.3 | 0.9 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 2.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.3 | 0.6 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.3 | 2.1 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 5.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.4 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.3 | 4.5 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 2.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.3 | 1.2 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.3 | 2.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 1.5 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.3 | 3.5 | GO:0038132 | neuregulin binding(GO:0038132) |
0.3 | 2.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.3 | 9.1 | GO:0031005 | filamin binding(GO:0031005) |
0.3 | 4.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.3 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.3 | 2.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.3 | 2.9 | GO:0045545 | syndecan binding(GO:0045545) |
0.3 | 1.7 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.3 | 2.6 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 1.1 | GO:0005115 | receptor tyrosine kinase-like orphan receptor binding(GO:0005115) chemoattractant activity involved in axon guidance(GO:1902379) |
0.3 | 0.8 | GO:0005497 | androgen binding(GO:0005497) |
0.3 | 1.1 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 4.5 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.3 | 2.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.3 | 0.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 0.8 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
0.3 | 3.6 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.3 | 1.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.3 | 0.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.3 | 0.8 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.3 | 0.5 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 1.3 | GO:0002046 | opsin binding(GO:0002046) |
0.3 | 0.8 | GO:0060001 | minus-end directed microfilament motor activity(GO:0060001) |
0.3 | 1.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.3 | 0.8 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.3 | 100.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.3 | 0.8 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.3 | 2.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.3 | 10.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 5.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.3 | 2.0 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.3 | 3.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 0.8 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.2 | 2.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.2 | 1.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.2 | 1.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.2 | 25.2 | GO:0005518 | collagen binding(GO:0005518) |
0.2 | 0.7 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.2 | 1.0 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
0.2 | 1.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 5.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.7 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
0.2 | 10.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.2 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
0.2 | 0.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 0.7 | GO:0045485 | omega-6 fatty acid desaturase activity(GO:0045485) |
0.2 | 8.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.2 | 0.7 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.2 | 0.7 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
0.2 | 1.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 0.4 | GO:0017129 | triglyceride binding(GO:0017129) |
0.2 | 3.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.2 | 0.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.2 | 2.6 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 1.3 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 6.6 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 6.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 4.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 0.6 | GO:0072544 | L-DOPA receptor activity(GO:0035643) L-DOPA binding(GO:0072544) |
0.2 | 1.0 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.2 | 0.8 | GO:0042806 | fucose binding(GO:0042806) |
0.2 | 3.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.6 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
0.2 | 1.2 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.2 | 1.8 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.2 | 0.8 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 1.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.2 | 3.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.2 | 0.2 | GO:0000248 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
0.2 | 4.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.2 | 2.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.2 | 0.6 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 0.6 | GO:0010858 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.2 | 0.6 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.2 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 0.6 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
0.2 | 5.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.2 | 3.5 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.2 | 0.6 | GO:0015322 | proton-dependent oligopeptide secondary active transmembrane transporter activity(GO:0005427) secondary active oligopeptide transmembrane transporter activity(GO:0015322) |
0.2 | 0.8 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.2 | 1.5 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 1.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.2 | 1.5 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.2 | 0.9 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.2 | 0.7 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.2 | 0.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 0.7 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.2 | 0.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 1.5 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.2 | 0.5 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 1.1 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 0.5 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.2 | 2.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.2 | 0.9 | GO:0016900 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 28.2 | GO:0008201 | heparin binding(GO:0008201) |
0.2 | 2.1 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 1.9 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.2 | 0.2 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.2 | 1.4 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.7 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.2 | 0.5 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.2 | 0.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 2.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.2 | 0.5 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
0.2 | 0.5 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.2 | 1.0 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.2 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.2 | 1.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 5.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.2 | 2.7 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 0.3 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
0.2 | 1.3 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.5 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.2 | 21.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 0.5 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
0.2 | 0.3 | GO:0030617 | transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity(GO:0030617) |
0.2 | 1.0 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 3.0 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.2 | 1.3 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.2 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 0.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.2 | 4.0 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.9 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.2 | 0.5 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.2 | 3.5 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.2 | 1.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.2 | 4.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 2.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 8.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 3.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 3.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.4 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 4.1 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.1 | 0.7 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 1.2 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.6 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.1 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 4.0 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.4 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 1.0 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.4 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.4 | GO:0072591 | citrate-L-glutamate ligase activity(GO:0072591) |
0.1 | 0.8 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.1 | 2.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.1 | 2.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.6 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.1 | 2.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.5 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.1 | 0.4 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.1 | 8.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.1 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 2.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.1 | 0.7 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 4.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 22.4 | GO:0008083 | growth factor activity(GO:0008083) |
0.1 | 0.3 | GO:0016886 | DNA ligase activity(GO:0003909) ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.8 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.1 | 0.3 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.1 | 1.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 1.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 4.5 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.8 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.1 | 1.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.5 | GO:0047946 | glutamine N-acyltransferase activity(GO:0047946) |
0.1 | 1.1 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 2.3 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 3.0 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.1 | 1.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 4.3 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.9 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
0.1 | 0.5 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.1 | 1.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 0.1 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) |
0.1 | 0.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 4.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.1 | 0.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 0.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.4 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.1 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 1.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.5 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.1 | 0.5 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.1 | 0.2 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.1 | 0.1 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.3 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
0.1 | 1.9 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 0.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.1 | 2.7 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.1 | 0.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.1 | 0.7 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 2.0 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.3 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.1 | 0.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
0.1 | 0.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.4 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.2 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 1.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.1 | 0.4 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.1 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 3.9 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 1.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.5 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.1 | 2.8 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 0.6 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.1 | 0.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.1 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.9 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.9 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.1 | 0.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 1.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.5 | GO:0052836 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
0.1 | 4.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 1.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 1.1 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.1 | 0.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.7 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 0.1 | GO:0051022 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.3 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.1 | 0.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 0.8 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.1 | 0.4 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 1.4 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.9 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.9 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 1.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 0.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.1 | 0.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 2.1 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.1 | 1.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.1 | 0.7 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.1 | 0.2 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.1 | 0.2 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 10.1 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.4 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.1 | 0.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.2 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.1 | 0.7 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.8 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 1.0 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.1 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 0.5 | GO:0004372 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.1 | 0.7 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.2 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.1 | 0.2 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.9 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
0.1 | 0.2 | GO:0050571 | 1,5-anhydro-D-fructose reductase activity(GO:0050571) |
0.1 | 0.7 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.2 | GO:0008892 | guanine deaminase activity(GO:0008892) |
0.1 | 0.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 1.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.5 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
0.1 | 0.2 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
0.1 | 0.5 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 1.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 0.8 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 0.5 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 1.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.1 | 0.3 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.2 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.6 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 2.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.5 | GO:0050733 | RS domain binding(GO:0050733) |
0.1 | 3.9 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.9 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 3.0 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.1 | 0.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.1 | 0.5 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.9 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.2 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.2 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
0.1 | 1.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 7.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 1.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.1 | 2.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.2 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.1 | 0.4 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 0.2 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.1 | 3.3 | GO:0017022 | myosin binding(GO:0017022) |
0.1 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 1.3 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.1 | 1.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 1.6 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.2 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 0.2 | GO:0033558 | protein deacetylase activity(GO:0033558) |
0.1 | 0.4 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.1 | 0.8 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.2 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.8 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.1 | 0.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.5 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.7 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.1 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.9 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.0 | 2.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.4 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.5 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.2 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.0 | 0.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.0 | 0.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.0 | 0.2 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.1 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.0 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.5 | GO:0035877 | death effector domain binding(GO:0035877) |
0.0 | 0.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.4 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.0 | 1.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.0 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.0 | 0.2 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.9 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.1 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
0.0 | 0.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.2 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.0 | 0.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.4 | GO:0016769 | transaminase activity(GO:0008483) transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.2 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.0 | 0.3 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.0 | 0.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 0.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.0 | 0.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.0 | 0.1 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.0 | 1.0 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.3 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 0.2 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.0 | 0.2 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 3.2 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.2 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.0 | 0.1 | GO:0015131 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.0 | 0.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.0 | GO:0004458 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.0 | 0.1 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.0 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.1 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.0 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 7.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0051908 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 3.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0032129 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.0 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.0 | 0.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.4 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.0 | 0.0 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.0 | 0.8 | GO:0046983 | protein dimerization activity(GO:0046983) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.1 | GO:0001133 | RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding(GO:0001133) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 0.2 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.1 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
0.0 | 0.3 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.0 | 0.1 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.0 | 2.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.1 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.0 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:1990175 | EH domain binding(GO:1990175) |
0.0 | 0.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.2 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.2 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.1 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.6 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.9 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.0 | 0.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 2.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 3.4 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.4 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.0 | 0.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0004803 | transposase activity(GO:0004803) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.1 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.0 | 0.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 0.7 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.1 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.2 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.0 | 0.0 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.0 | 0.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.0 | 0.0 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.1 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.0 | 0.0 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.3 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 1.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.0 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 41.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.5 | 1.0 | PID IGF1 PATHWAY | IGF1 pathway |
0.4 | 9.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 17.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.4 | 1.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 0.7 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 99.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 0.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.3 | 15.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.2 | 9.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 12.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 0.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.2 | 1.8 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.2 | 7.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 14.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 57.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.2 | 6.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 4.7 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 9.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 67.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 6.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 4.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 5.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 34.4 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 5.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 7.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 4.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 5.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 1.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 4.9 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 4.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.5 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.1 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.5 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 4.4 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.1 | 4.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 3.4 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 1.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.0 | 1.4 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.8 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 1.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 3.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.1 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 13.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.6 | 18.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.5 | 0.5 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.5 | 13.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.5 | 6.4 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.5 | 40.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.5 | 8.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.4 | 0.4 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.4 | 18.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.4 | 11.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 8.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 3.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.3 | 7.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.3 | 8.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.3 | 5.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 4.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.3 | 8.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.3 | 15.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 2.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 17.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.2 | 8.1 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 7.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 24.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 5.0 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.2 | 5.8 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 10.8 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 0.9 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 2.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 2.6 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.2 | 3.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 8.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 3.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.2 | 2.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.2 | 1.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 3.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 5.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 1.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.7 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 5.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 2.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 3.5 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 4.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 8.0 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 4.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 3.9 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 3.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.1 | 2.0 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.1 | 4.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.6 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.1 | 2.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 2.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 4.1 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.1 | 2.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.5 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 6.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 3.0 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 8.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.7 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.1 | 1.9 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 3.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.1 | 11.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.1 | 1.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.6 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.1 | 2.6 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 4.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 15.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.1 | 0.8 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
0.1 | 2.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.9 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 1.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.1 | 2.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 6.8 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 0.9 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.8 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.1 | 0.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.3 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 4.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 4.3 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 2.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.1 | 0.8 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.1 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.2 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.0 | 2.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.8 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 2.7 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.1 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.0 | 0.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.4 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.0 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 2.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.1 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.0 | 1.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.8 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.8 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 1.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.0 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.9 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 2.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.2 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |